Ramy Hanna FASN FACP FNKF
@RMHUCINEPHRO
Followers
2K
Following
1K
Media
28
Statuses
728
Associate Professor at UCI Nephrology. now associate Fellowship PD. This account is 100% medicine and nephrology related only. views=my own.
Seal Beach, CA
Joined March 2018
Obinutuzumab got approved for #LupusNephritis a few days ago and now this good news 🙌 I am SO thrilled for our patients!!
The #FDA has approved Rybelsus, an oral semaglutide dose, for the reduction of cardiovascular risk in patients with type 2 diabetes. It is now the first and only oral GLP-1 to receive approval. Read more: https://t.co/srLGHfzcqQ
0
1
9
What is the role of genetic testing in atypical hemolytic uremic syndrome? This #ASNCJASN Kidney Case Conference shares perspective: https://t.co/KhVu6FvSq9
1
9
33
Welcome @KatherineTuttl8 2025 Kirschenbaum visiting professor #kidneyhealth #diabetes #hypertension
@UCIkidney @HarborKidney
1
4
15
Time line of advances made in membranous nephropathy. The clinical significance of each antigen is explained. Time to diagnose, evaluate and treat MN based on the antigen. https://t.co/tgNGJJqEob
nature.com
Nature Reviews Nephrology - Since the discovery of PLA2R, several target antigens associated with membranous nephropathy have been identified. This Review describes the distinct clinical...
4
50
115
Thank you @nkf and @AlexionPharmaUS for sponsoring this important discussion on shared decision making in atypical HUS with experts @TaylorACoffman and @RMHUCINEPHRO
@ISMMSKidney
https://t.co/oSduJAcnxd
1
3
11
UCI faculty Dr. Ramy Hanna @RMHUCINEPHRO featured in @nkf podcast "Shared Decision Making in Atypical Hemolytic Uremic Syndrome" #aHUS #nephrology #RareDiseases
It was my pleasure to partner with @aHUSAlliance and the @nkf with @HollyMarieMD and featuring the incomparable @TaylorACoffman for a discussion on patient awareness, provider awareness, and advocacy in aHUS. https://t.co/YAVWvP5tUL
@nephcure @UCIrvineHealth
1
1
3
It was my pleasure to partner with @aHUSAlliance and the @nkf with @HollyMarieMD and featuring the incomparable @TaylorACoffman for a discussion on patient awareness, provider awareness, and advocacy in aHUS. https://t.co/YAVWvP5tUL
@nephcure @UCIrvineHealth
0
3
8
Complex Etiologies of the Discordance Between Cystatin C– and Creatinine-Based Estimated GFR and Its Adverse Associations: Findings From the @CRICStudy
https://t.co/5jbtnrpKRH
@NephroNinja @asgmd1 @JonTaliercio_DO @sylviaerosas @markunruh_01
2
18
42
FAT1 is the target antigen in membranous nephropathy associated with- 1. Stem cell transplant (HSCT) 2. Antibody mediated rejection (ABMR) in allograft. In this paper we show a temporal ⬆️of FAT1 in MN with ABMR using protocol & for cause biopsies. https://t.co/kEPANveTiB 1/2
kireports.org
Membranous nephropathy (MN) of the kidney allograft can represent recurrent, de novo, and very rarely, donor-derived disease. Despite its negative impact on allograft survival,1 our understanding of...
2
43
96
You had me at reduced complement activation Pilot study of SGLT-2 inhibitor empagliflozin shows reduced intrarenal complement activation in patients with diabetes and chronic kidney disease
kireports.org
Sodium-glucose cotransporter 2 inhibitors (SGLT-2i’s) improve kidney and cardiovascular outcomes in patients with diabetic nephropathy beyond antihypertensive and glucose-lowering effects.1 In...
1
12
46
Borrowed from @Nephtales #nephsky 🦋 As @TheLancet says “Nephrology is not for normal doctors” ❤️💙 https://t.co/aa4v6a8ReZ
4
69
191
Check out @ASNKidney Podcast 🎧 on “Novel Therapies for IgA Nephropathy (IgAN)” with @Nephro_Sparks
#KidneyWk #Nephpearls 📌 Efficacy and Safety of Ravulizumab in IgAN: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial 📌 The Selective Endothelin Receptor Antagonist
0
34
88
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy | New England Journal of Medicine
nejm.org
The alternative complement pathway plays a key role in the pathogenesis of IgA nephropathy. Iptacopan specifically binds to factor B and inhibits the alternative pathway. In this phase 3, double-bl...
1
6
30
Dr Valenti describing prolonged bedrest as a model to study hypercalciuria and #kidneystone risk in astronauts #SimulatedMicrogravity There is decrease in vasopressin, decreased protective factor osteopontin #KidneyWk2024
0
1
5
Met the one and only Dr Tangri and #epidemiology guru @eric_weinhandl
#nephrology has the brightest and nicest ppl in medicine 😊 #KidneyWk @ASNKidney
4
2
15
Go say hi to my TREKS mentee med student Frank Lee at his 2 posters 406 and 864 ! #KidneyWk2024
0
2
7
Go say hi to my postdocs Dr Zhao and Dr Lee at 1169 and 1194 ! Especially 1194 she’s in very end of the hall… #KidneyWk2024
0
2
6
Matthew Nguyen ms4 presenting c5 blockade resistant cm-tma with factor B… under compassionate use authorization… courtesy of Novartis
4
0
10
Anti vegf renal toxicity registry @ASNKidney 2024
0
0
2